Small Molecules in Oncology

Extensive research into the molecular mechanisms of cancer disease has heralded a new age of targeted therapy. In malignant cells, key proteins that are crucial to tumor growth and survival are now being targeted directly with rationally designed inhibitors. Apart from monoclonal antibodies, small m...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Martens, Uwe M. (Editor)
Format: Electronic
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg, 2010.
Series:Recent Results in Cancer Research, 184
Subjects:
Online Access:https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-3-642-01222-8
LEADER 02491nam a22004695i 4500
001 9865
003 DE-He213
005 20130725194750.0
007 cr nn 008mamaa
008 100301s2010 gw | s |||| 0|eng d
020 # # |a 9783642012228  |9 978-3-642-01222-8 
024 7 # |a 10.1007/978-3-642-01222-8  |2 doi 
050 # 4 |a RC254-282 
072 # 7 |a MJCL  |2 bicssc 
072 # 7 |a MED062000  |2 bisacsh 
082 0 4 |a 616.994  |2 23 
100 1 # |a Martens, Uwe M.  |e editor. 
245 1 0 |a Small Molecules in Oncology  |c edited by Uwe M. Martens.  |h [electronic resource] / 
264 # 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg,  |c 2010. 
300 # # |a XVI, 238p. 54 illus., 22 illus. in color.  |b online resource. 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a computer  |b c  |2 rdamedia 
338 # # |a online resource  |b cr  |2 rdacarrier 
347 # # |a text file  |b PDF  |2 rda 
490 1 # |a Recent Results in Cancer Research,  |v 184  |x 0080-0015 ; 
505 0 # |a Protein kinase inhibitors: Imatinib. Erlotinib. Axitinib. Lapatinib. Sorafenib. Sunitinib. Dasatinib. Nilotinib. Bosutinib -- Epigenetic modifiers: Decitabine. 5-Aza -- Cell cycle inhibitors: Bortezomib. Temsirolimus. PHA-739. Bl2536 -- Other novel agents: Imetelstat. GDC-0449. 
520 # # |a Extensive research into the molecular mechanisms of cancer disease has heralded a new age of targeted therapy. In malignant cells, key proteins that are crucial to tumor growth and survival are now being targeted directly with rationally designed inhibitors. Apart from monoclonal antibodies, small molecule therapeutics such as oncogenic protein kinase inhibitors are attracting a vast amount of investigational attention. This textbook, written by acknowledged experts, provides a broad overview of the small molecules currently used for the treatment of malignant diseases and discusses interesting novel compounds that are in the process of clinical development to combat cancer. 
650 # 0 |a Medicine. 
650 # 0 |a Oncology. 
650 # 0 |a Hematology. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Oncology. 
650 2 4 |a Hematology. 
650 2 4 |a Cancer Research. 
710 2 # |a SpringerLink (Online service) 
773 0 # |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783642012211 
830 # 0 |a Recent Results in Cancer Research,  |v 184  |x 0080-0015 ; 
856 4 0 |u https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-3-642-01222-8 
912 # # |a ZDB-2-SME 
950 # # |a Medicine (Springer-11650)